Shares of Ami Organics Ltd. jumped over 6% to the highest in over a month on Monday after the government granted it two process patents for 20 years.
The pharmaceutical firm has got patents for the process for preparation of 2-(Piperidin-4-YL)-1H-benzo[D]imidazole, and a process for the direct synthesis of a Fedratinib intermediate, according to an exchange filing on Saturday.
After receiving these two patents, the company now has a total of nine patents for its innovative process and technologies, it said.
On the NSE, Ami Organics' stock rose as much as 6.20% during the day to Rs 1,185.50 apiece, the highest since Jan. 29. It was trading 4.28% higher at Rs 1,164.05 per share, compared to a 0.16% advance in the benchmark Nifty 50 at 11:17 a.m.
The share price has risen 23.22% in the last 12 months. The total traded volume so far in the day stood at 5.1 times its 30-day average. The relative strength index was at 61.37.
Six out of the eight analysts tracking the company have a 'buy' rating on the stock, one recommends 'hold' and another suggests 'sell', according to Bloomberg data. The average of 12-month analyst price targets implies a potential downside of 0.3%.
RECOMMENDED FOR YOU
Epic Games' Win Over Google In Fortnite Fight Upheld On Appeal
Jul 31, 2025
Tata Steel To Explore New Markets As Tariffs Hit US Shipments
Jul 31, 2025
Delhi Rains: Light Showers Hit National Capital Minimum Temperature Down 1.5 Notches
Jul 27, 2025
Haj Committee Of India Opens Application Process For 2026 Pilgrimage
Jul 09, 2025
POPULAR